Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.

Presented by the Consulate General of Canada, the Canadian healthcare startup showcase included five companies. Technologies included a patient transfer solution, care coordination, women’s health, exercise tracking and remote monitoring for dysphagia, and mental health support.

The MedCity INVEST conference included a panel discussion on raising public venture capital in Canada, sponsored by Cozen O’Connor and TSX.

Bausch + Lomb drug Miebo is now FDA approved as a new treatment for dry eye disease. Unlike many products that rewet the eye, Miebo is designed to address one of the factors that leads to dry eyes.

Five companies will take part in the showcase with technologies addressing mental health, care coordination, aging in place, physical therapy and more. Register for INVEST, scheduled for May 22-24, at the Ritz Carlton in Chicago!

The Consulate General of Canada in Chicago is currently celebrating the 75th anniversary of its diplomatic presence in the Midwest.

Recursion Pharmaceuticals is acquiring two Canada-based artificial intelligence startups, Cyclica and Valence. The “biology-first company” says both deals build up its capability to apply AI to the chemistry side of drug discovery.

At the MedCity INVEST conference this week, a panel discussion highlighted the benefits of going public in Canada as an alternative path for young growth stage companies to raise capital.

Founder and CEO Hedieh Safiyari talks about the Canadian healthcare startup on a mission to revolutionize the health and wellness experience.

The Tianjin, China-based company and a Canadian federal research institution plan to advance bioprocessing and clinical development of Ad5-nCoV in Canada. CanSinoBIO is currently running a Phase II clinical trial in China.

The immersive medical education software company is applying its medical-grade virtual reality platform to train surgeons.

Drug regulators in the U.S., Canada and Australia simultaneously approved Merck’s Keytruda and Eisai’s Lenvima for advanced endometrial carcinoma following a collaborative review under a program called Project Orbis.

The Salvation Army Toronto Grace Health Centre will utilize the home care company’s approach and technology solutions to reduce emergency department visits and hospital readmissions.

Peter Bak, CIO of Humber River Hospital in Toronto, highlighted his organization’s digital efforts around systems automation, connectivity and an analytics-focused command center.

The Canadian company’s shares reached a high price after it signed a framework agreement with Novartis’s generics arm that would enable global commercialization.

The organization, which leverages technology to provide care to seniors in their own homes, also serves the Toronto and New York City markets.

Greater transparency about conflicts of interest could curb punitive actions like MSKCC executive’s resignation last month, study author says.

The Canadian startup secured C$62 million (or about $47.5 million) in a round led by TELUS Ventures. Wittington Ventures, OMERS, RBC Ventures, Real Ventures, Infinite Potential Group and BDC IT Venture Fund also participated in the round.

Redox’s deal with PointClickCare was its first partnership in senior care and could improve the way data is shared in the longterm care sector.

Congress has passed legislation legalizing the importation of prescription drugs several times in the past 20 years, but both Democratic and Republican administrations have opted not to implement it.

Four recent engineering graduates from McMaster University, near Toronto, built a device to detect melanoma that measures the temperature differences between melanoma and normal tissue.

Genetesis and Analytics 4 Life have developed non-invasive approaches to cardiac diagnostics.

Which EHR vendors were the hottest across the globe? The KLAS “Global EMR Market Share 2017” report analyzes new hospital EHR contracts that happened all over the world in 2016.

Do doctors need a shot of empathy? Researchers at a Canadian digital healthcare marketing company think so, and say they can administer it wirelessly.

The U.S. drug industry has strongly opposed efforts to open the borders to drug imports, but pharma lobbying group PhRMA is not mentioned in the Partnership for Safer Medicines’ advertising blitz.

Aurinia Pharmaceuticals put cashflow issues behind it on Tuesday, announcing a public offering that it expects will generate $150.5 million in gross proceeds for its Phase 3 trial in lupus nephritis. But not everyone was happy with the news.

Meta developed software to analyze and connect insights across millions of scientific papers, according to a description of the company on Chan Zuckerberg Initiative’s Facebook page.

We need a better way forward, one which protects the networks and IP of established eHealth companies, while also enabling active innovation from the eHealth community.

So far, investments from Relay Ventures’ third fund include personal wellness tracker OMsignal and health incentives startup CARROT Insights.

Intellijoint Surgical has developed an optical navigation system to properly position artificial hips, and with $11 million raised in a Series A round, plans further expansion in the U.S.